Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia

Glucose and lipid metabolism are linked to each other in many ways. The most important clinical manifestation of this interaction is diabetic dyslipidemia, characterized by elevated triglycerides, low high density lipoprotein cholesterol (HDL-C), and predominance of small-dense LDL particles. Howeve...

Full description

Bibliographic Details
Main Author:	Klaus G. Parhofer
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2015-10-01
Series:	Diabetes & Metabolism Journal
Subjects:	Diabetes mellitus Diabetic dyslipidemia Hyperlipoproteinemia type II Hyperlipoproteinemias Statin
Online Access:	http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-353.pdf

Similar Items

Ghrelin Levels in Male Patients with Hyperlipoproteinemia I, II versus Type 2 Diabetes Mellitus.
by: Salma A. Abbas, et al.
Published: (2014-07-01)

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia
by: Ya-Hui Chang, et al.
Published: (2022-12-01)

Familial hypercholesterolemia within cardiology practice – single-center experience during 2-year period
by: Edin Begic, et al.
Published: (2022-01-01)

Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia
by: Maria Cristina de Oliveira Izar, et al.

Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene
by: Ka Young Kim, et al.
Published: (2024-04-01)

Assessment of the Relationship between Hyperlipoproteinemias and Biliary Lithiasis
by: Dan BANUT, et al.
Published: (2009-01-01)

Molecular diagnosis methods in familial hypercholesterolemia
by: Valeriu Moldovan, et al.
Published: (2020-02-01)

Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state
by: Caroline Marcoux, et al.
Published: (2000-09-01)

C3 POLYMORPHISM IN HYPERLIPOPROTEINEMIA (HLP)
by: D.D. FARHUD
Published: (1989-08-01)

2022 Consensus statement on the management of familial hypercholesterolemia in Korea
by: Chan Joo Lee, et al.
Published: (2022-09-01)

A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
by: Pinilla-Monsalve GD, et al.
Published: (2020-03-01)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
by: Sung Hye Kong, et al.
Published: (2017-01-01)

PARTICIPATION OF APOLIPOPROTEIN E IN TRANSFER AND ABSORPTION OF FATTY ACIDS BY THE CELLS And CAUSING OF HYPERLIPOPROTEINEMIA
by: V. N. Titov, et al.
Published: (2014-02-01)

Multiple molecular-genetic defects in a female with mixed hyperlipoproteinemia and earlyischemic heart disease
by: P P Malyshev, et al.
Published: (2003-10-01)

The transport of α-tocopherol and β-carotene in human blood
by: L K Bjornson, et al.
Published: (1976-07-01)

A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia
by: Rachele M. Hendricks-Sturrup, et al.
Published: (2020-04-01)

Changes in Alanine transaminase levels in response to statins: Sri Lankan experience in patient with type 2 Diabetes mellitus with Dyslipidemia
by: C.N. Antonypillai, et al.
Published: (2018-04-01)

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series
by: A. M. Namitokov, et al.
Published: (2023-12-01)

Characterization of guinea pig plasma lipoproteins: the appearance of new lipoproteins in response to dietary cholesterol
by: Christian Sardet, et al.
Published: (1972-09-01)

Yüksek frekanslı tinnitusu olan hastalarda serum lipid profili
by: Yusuf Çağdaş Kumbul, et al.
Published: (2021-03-01)

Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL
by: Stewart C. Whitman, et al.
Published: (1998-05-01)

Low circulating PCSK9 levels in LPL homozygous children with chylomicronemia syndrome in a syrian refugee family in Lebanon
by: Carine Ayoub, et al.
Published: (2022-08-01)

Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization
by: Ya-Ching Chang, et al.
Published: (2023-09-01)

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
by: Tenenbaum Alexander, et al.
Published: (2004-12-01)

Características de los casos con dislipidemias mixtas en un estudio de población: resultados de la Encuesta Nacional de Enfermedades Crónicas Characteristics of mixed hyperlipidemia cases in a population-based study: results from the Mexican National Survey of Chronic Diseases
by: Carlos A Aguilar-Salinas, et al.
Published: (2002-11-01)

Evaluation of dyslipidemia in type 2 diabetes mellitus
by: Devendra Pratap Singh Rajput
Published: (2015-05-01)

Dyslipidemia Treatment and Lipid Control in US Adults with Diabetes by Sociodemographic and Cardiovascular Risk Groups in the NIH Precision Medicine Initiative <i>All of Us</i> Research Program
by: Meleeka Akbarpour, et al.
Published: (2023-02-01)

Dyslipidemia in diabetes
by: Sanjay Kalra, et al.
Published: (2024-03-01)

Efecto del aceite de sacha inchi (plukenetia volúbilis l) sobre el perfil lipídico en pacientes con hiperlipoproteinemia Effect of sacha inchi oil (plukenetia volúbilis l) on the lipid profile of patients with hyperlipoproteinemia
by: Fausto Garmendia, et al.
Published: (2011-12-01)

Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
by: Nadeem Qureshi, et al.
Published: (2023-10-01)

THE ROLE OF DYSLIPIDEMIA IN THE PROGRESSION OF DIABETIC RETINOPATHY
by: A. G. Kuzmin, et al.
Published: (2017-12-01)

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
by: Sang-Hak Lee
Published: (2017-01-01)

Cost-effectiveness analysis of statin monotherapy regimen in outpatient management of dyslipidemia in patients with diabetes mellitus
by: Khemachitra Saneewong Na Ayuttaya, et al.
Published: (2014-12-01)

Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene
by: Evans D, et al.
Published: (2011-02-01)

Electrophoretic separation of plasma lipoproteins in agarose gel
by: Robert P. Noble
Published: (1968-11-01)

Therapeutic management of hyperlipoproteinemia (a)
by: Constantine E Kosmas, et al.
Published: (2019-09-01)

Recent dyslipidemia guidelines for patients with diabetes mellitus
by: Eun-Jung Rhee
Published: (2020-12-01)

Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
by: Brian Tomlinson, et al.
Published: (2021-04-01)

Role of dyslipidemia in the development of nephropathy in patients with type 2 diabetes mellitus (literature review)
by: S.I. Ismailov, et al.
Published: (2019-11-01)

Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus – A countrywide study in Bangladesh
by: A.B.M. Kamrul-Hasan, et al.
Published: (2023-12-01)